OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
Qingling Yang, Yangyang Wang, Xiaohui Lü, et al.
Oncotarget (2014) Vol. 6, Iss. 5, pp. 3268-3279
Open Access | Times Cited: 105
Qingling Yang, Yangyang Wang, Xiaohui Lü, et al.
Oncotarget (2014) Vol. 6, Iss. 5, pp. 3268-3279
Open Access | Times Cited: 105
Showing 1-25 of 105 citing articles:
Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Bowen Du, Joong Sup Shim
Molecules (2016) Vol. 21, Iss. 7, pp. 965-965
Open Access | Times Cited: 701
Bowen Du, Joong Sup Shim
Molecules (2016) Vol. 21, Iss. 7, pp. 965-965
Open Access | Times Cited: 701
Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance
Hassan Yousefi, Maryam Maheronnaghsh, Fatemeh Molaei, et al.
Oncogene (2019) Vol. 39, Iss. 5, pp. 953-974
Closed Access | Times Cited: 187
Hassan Yousefi, Maryam Maheronnaghsh, Fatemeh Molaei, et al.
Oncogene (2019) Vol. 39, Iss. 5, pp. 953-974
Closed Access | Times Cited: 187
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111824-111824
Open Access | Times Cited: 155
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111824-111824
Open Access | Times Cited: 155
Mechanisms of Taxane Resistance
Sara Maloney, Camden A. Hoover, Lorena V. Morejon-Lasso, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3323-3323
Open Access | Times Cited: 145
Sara Maloney, Camden A. Hoover, Lorena V. Morejon-Lasso, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3323-3323
Open Access | Times Cited: 145
Functional miRNAs in breast cancer drug resistance
Weizi Hu, Chunli Tan, Yunjie He, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 1529-1541
Open Access | Times Cited: 113
Weizi Hu, Chunli Tan, Yunjie He, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 1529-1541
Open Access | Times Cited: 113
MicroRNA-125 in immunity and cancer
Jessica K. Wang, Zhe Wang, Guideng Li
Cancer Letters (2019) Vol. 454, pp. 134-145
Closed Access | Times Cited: 113
Jessica K. Wang, Zhe Wang, Guideng Li
Cancer Letters (2019) Vol. 454, pp. 134-145
Closed Access | Times Cited: 113
Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
Wenrui Wang, Lingyu Zhang, Yangyang Wang, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 10, pp. e3071-e3071
Open Access | Times Cited: 107
Wenrui Wang, Lingyu Zhang, Yangyang Wang, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 10, pp. e3071-e3071
Open Access | Times Cited: 107
Vasculogenic mimicry, a complex and devious process favoring tumorigenesis – Interest in making it a therapeutic target
Lucas Treps, Sébastien Faure, Nicolas Clere
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107805-107805
Open Access | Times Cited: 66
Lucas Treps, Sébastien Faure, Nicolas Clere
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107805-107805
Open Access | Times Cited: 66
Emerging roles and mechanisms of semaphorins activity in cancer
Cecilia Bica, Alexandru Tirpe, Andreea Nuțu, et al.
Life Sciences (2023) Vol. 318, pp. 121499-121499
Closed Access | Times Cited: 23
Cecilia Bica, Alexandru Tirpe, Andreea Nuțu, et al.
Life Sciences (2023) Vol. 318, pp. 121499-121499
Closed Access | Times Cited: 23
Exosomal long non-coding RNAs in cancer: Interplay, modulation, and therapeutic avenues
Rahaba Marima, Afra Basera, Thabiso Victor Miya, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 887-900
Open Access | Times Cited: 14
Rahaba Marima, Afra Basera, Thabiso Victor Miya, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 887-900
Open Access | Times Cited: 14
Revenge Unraveling the Fortress: Exploring Anticancer Drug Resistance Mechanisms in BC for Enhanced Therapeutic Strategies
Ashi Mannan, Maneesh Mohan, Thakur Gurjeet Singh
Critical Reviews in Oncology/Hematology (2025), pp. 104707-104707
Closed Access | Times Cited: 1
Ashi Mannan, Maneesh Mohan, Thakur Gurjeet Singh
Critical Reviews in Oncology/Hematology (2025), pp. 104707-104707
Closed Access | Times Cited: 1
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression
И. В. Пронина, В. И. Логинов, A. M. Burdennyy, et al.
Gene (2016) Vol. 604, pp. 1-8
Closed Access | Times Cited: 81
И. В. Пронина, В. И. Логинов, A. M. Burdennyy, et al.
Gene (2016) Vol. 604, pp. 1-8
Closed Access | Times Cited: 81
Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells
Lixia Wang, Xiantao Ye, Xingming Cai, et al.
Oncotarget (2015) Vol. 6, Iss. 20, pp. 18027-18037
Open Access | Times Cited: 75
Lixia Wang, Xiantao Ye, Xingming Cai, et al.
Oncotarget (2015) Vol. 6, Iss. 20, pp. 18027-18037
Open Access | Times Cited: 75
Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential
Sreeharsha Gurrapu, Emanuela Pupo, Giulia Franzolin, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 7, pp. 1259-1275
Open Access | Times Cited: 72
Sreeharsha Gurrapu, Emanuela Pupo, Giulia Franzolin, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 7, pp. 1259-1275
Open Access | Times Cited: 72
MiR‐138 inhibits cell proliferation and reverses epithelial‐mesenchymal transition in non‐small cell lung cancer cells by targeting GIT 1 and SEMA 4C
Jiefang Li, Qinrong Wang, Ruiling Wen, et al.
Journal of Cellular and Molecular Medicine (2015) Vol. 19, Iss. 12, pp. 2793-2805
Open Access | Times Cited: 71
Jiefang Li, Qinrong Wang, Ruiling Wen, et al.
Journal of Cellular and Molecular Medicine (2015) Vol. 19, Iss. 12, pp. 2793-2805
Open Access | Times Cited: 71
Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer
Mariyam Zuberi, Imran Khan, Rashid Mir, et al.
PLoS ONE (2016) Vol. 11, Iss. 4, pp. e0153902-e0153902
Open Access | Times Cited: 67
Mariyam Zuberi, Imran Khan, Rashid Mir, et al.
PLoS ONE (2016) Vol. 11, Iss. 4, pp. e0153902-e0153902
Open Access | Times Cited: 67
miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1
Bingshou Li, Lin Liu, Xiaoming Li, et al.
Biochemical and Biophysical Research Communications (2015) Vol. 464, Iss. 4, pp. 982-987
Closed Access | Times Cited: 66
Bingshou Li, Lin Liu, Xiaoming Li, et al.
Biochemical and Biophysical Research Communications (2015) Vol. 464, Iss. 4, pp. 982-987
Closed Access | Times Cited: 66
EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer.
Jin Ma, Jun Zhang, Yuanchi Weng, et al.
PubMed (2018) Vol. 41, Iss. 9, pp. 868-880
Closed Access | Times Cited: 64
Jin Ma, Jun Zhang, Yuanchi Weng, et al.
PubMed (2018) Vol. 41, Iss. 9, pp. 868-880
Closed Access | Times Cited: 64
Essential functions of miR‐125b in cancer
Boya Peng, Poh Ying Theng, Minh T. N. Le
Cell Proliferation (2020) Vol. 54, Iss. 2
Open Access | Times Cited: 61
Boya Peng, Poh Ying Theng, Minh T. N. Le
Cell Proliferation (2020) Vol. 54, Iss. 2
Open Access | Times Cited: 61
Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer
Roberta Mastrantonio, Hua You, Luca Tamagnone
Theranostics (2021) Vol. 11, Iss. 7, pp. 3262-3277
Open Access | Times Cited: 44
Roberta Mastrantonio, Hua You, Luca Tamagnone
Theranostics (2021) Vol. 11, Iss. 7, pp. 3262-3277
Open Access | Times Cited: 44
The Role of MicroRNAs in the Chemoresistance of Breast Cancer
Jing Wang, Muyi Yang, Yu Li, et al.
Drug Development Research (2015) Vol. 76, Iss. 7, pp. 368-374
Closed Access | Times Cited: 64
Jing Wang, Muyi Yang, Yu Li, et al.
Drug Development Research (2015) Vol. 76, Iss. 7, pp. 368-374
Closed Access | Times Cited: 64
Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer
Baoquan Liu, Fei Su, Mingwei Chen, et al.
Human Pathology (2017) Vol. 64, pp. 44-52
Closed Access | Times Cited: 56
Baoquan Liu, Fei Su, Mingwei Chen, et al.
Human Pathology (2017) Vol. 64, pp. 44-52
Closed Access | Times Cited: 56
Concentrates of two subsets of extracellular vesicles from cow’s milk modulate symptoms and inflammation in experimental colitis
Abderrahim Benmoussa, Idrissa Diallo, Mabrouka Salem, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Abderrahim Benmoussa, Idrissa Diallo, Mabrouka Salem, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
Zhiqiang Ye, Shengli Yin, Zhongzhen Su, et al.
Oncotarget (2016) Vol. 7, Iss. 25, pp. 37524-37535
Open Access | Times Cited: 53
Zhiqiang Ye, Shengli Yin, Zhongzhen Su, et al.
Oncotarget (2016) Vol. 7, Iss. 25, pp. 37524-37535
Open Access | Times Cited: 53
MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1
Kun Yao, Leye He, Yu Gan, et al.
Diagnostic Pathology (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 50
Kun Yao, Leye He, Yu Gan, et al.
Diagnostic Pathology (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 50
